Search Results

Abstracts
The evaluation of a 5-plex “rainbow” digital PCR assays to measure intact HIV-1 proviral DNA
M. Delporte Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Detection of mutations associated with antiretroviral drug resistance from HIV proviral DNA in patients with low-level viremias
P. Ferrer Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Challenges of remdesivir pediatric development for SARS-CoV-2 infection in a pandemic
C. Pikora Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Experience, attitudes, and indirect impact of the COVID-19 pandemic in adolescents living with HIV in Abidjan, Côte d’Ivoire: a cross-sectional analysis at inclusion in the IeDEA-OPTIMISE-WA trial.
M.H. Dassi Tchoupa Revegue. Reviews in Antiviral Therapy & Infectious Diseases 9, 2021
Presented at:
International Workshop on HIV & Adolescence 2021
Slidesets
What is the Pharmacological support for reduced drug regimens?- Esteban Ribera, MD, PhD
Presented at:
Spanish HIV Clinical Forum 2018
Slidesets
Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice | Anaïs Corma
Presented at:
International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018
Slidesets
Service Delivering Models - Health Inequalities in General - Eamonn Murphy
Presented at:
International Workshop on Innovations in Delivery of HIV Care 2021